Conversely, in the MOG35–55-induced EAE model of MS, FGF2 deficiency results in a more severe disease course, increased infiltration of lymphocytes and macrophages, and reduced remyelination [170]. The gene discussed is FGF2; the disease is myeloid sarcoma.